Facilitatory interplay in α1a and β2 adrenoceptor function reveals a non-Gq signaling mode: Implications for diversification of intracellular signal transduction

Molecular Pharmacology

Volumn 75, Issue 3, 2009, Pages 713-728

  Copik, Alicja J ^a   Ma, Cynthia ^a   Kosaka, Alan ^b   Sahdeo, Sunil ^a   Tranes, Andy ^a   Ho, Hoangdung ^b   Dietrich, Paul S ^b   Yu, Helen ^b   Ford, Anthony P D W ^a   Button, Donald ^a   Milla, Marcos E ^a  

^a Inflammation Discovery ^*  (United States)

^b Discovery Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; ALPHA 1A ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; ISOPRENALINE; N [5 (4,5 DIHYDRO 1H IMIDAZOL 2 YL) 5,6,7,8 TETRAHYDRO 2 HYDROXY 1 NAPHTHYL]METHANESULFONAMIDE; NORADRENALIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; XESTOSPONGIN C; ADRENERGIC RECEPTOR ALPHA(1A); ALPHA 1 ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN VARIANT; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; CELL LINE; COMPARATIVE STUDY; HEART FAILURE; INTRACELLULAR MEMBRANE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY;

AMINO ACID SEQUENCE; CELL LINE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HEART FAILURE; HUMANS; INTRACELLULAR MEMBRANES; MOLECULAR SEQUENCE DATA; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 62149102644     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.050765     Document Type: Article

References (56)

1. ALLHAT (2000) Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 283:1967-1975.
2. Berjukow S, Döring F, Frosehmayr M, Grabner M, Glossmann H, and Hering S (1996) Endogenous calcium channels in human embryonic kidney (HEK293) cells. Br J Pharmacol 118:748-754.
3. Berridge MJ, Bootman MD, and Roderick HL (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4:517-529.
4. Boffa LC, Vidali G, Mann RS, and Allfrey VG (1978) Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J Biol Chem 253:3364-3366.
5. Brodde OE (1991) Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203-242.
6. Bugaj V, Alexeenko V, Zubov A, Glushankova L, Nikolaev A, Wang Z, Kaznacheyeva E, Bezprozvanny I, and Mozhayeva GN (2005) Functional properties of endogenous receptor-and store-operated calcium influx channels in HEK293 cells. J Biol Chem 280:16790-16797.
7. Carrillo JJ, Pediani J, and Milligan G (2003) Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins. J Biol Chem 278:42578-42587.
8. Catterall WA, Hulme JT, Jiang X, and Few WP (2006) Regulation of sodium and calcium channels by signaling complexes. J Recept Signal Transduct Res 26:577-598.
9. Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
10. Clapham DE (2007) Calcium signaling. Cell 131:1047-1058.
11. Cooper J, Hill SJ, and Alexander SP (1997) An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells. Br J Pharmacol 122:546-550.
12. Cordeaux Y and Hill SJ (2002) Mechanisms of cross-talk between G-protein-coupled receptors. Neuro-Signals 11:45-57.
13. Cotecchia S, Exum S, Caron MG, and Lefkowitz RJ (1990) Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proe Natl Acad Sci USA 87:2896-2900.
14. D'Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, and Dorn GW 2nd (1997) Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA 94:8121-8126.
15. 2+ channel Cavl.2. Science 293:98-101.
16. Dzimiri N (2002) Receptor crosstalk: implications for cardiovascular function, disease and therapy. Eur J Biochem 269:4713-4730.
17. Feldman DS, Elton TS, Sun B, Martin MM, and Ziolo MT (2008) Mechanisms of disease: detrimental adrenergic signaling in acute, decompensated heart failure. Nat Clin Pract Cardiovasc Med 5:208-218.
18. 2+ channels in COS-7 cells. J Physiol 543:425-437.
19. Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD, and Clarke DE (1997) Pharmacological pleiotropism of the human recombinant alphalA- adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol 121:1127-1135.
20. Gilchrist A (2007) Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics. Trends Pharmacol Sci 28:431-437.
21. Greasley PJ, Fanelli F, Scheer A, Abuin L, Nenniger-Tosato M, DeBenedetti PG, and Cotecchia S (2001) Mutational and computational analysis of the alpha(lb)-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling. J Biol Chem 276:46485-46494.
22. Higashida H, Salmina AB, Olovyannikova RY, Hashii M, Yokoyama S, Koizumi K, Jin D, Liu HX, Lopatina O, Amina S, et al. (2007) Cyclic ADP-ribose as a universal calcium signal molecule in the nervous system. Neurochem Int 51:192-199.
23. Hoffmann C, Gaietta G, Bünemann M, Adams SR, Oberdorff-Maass S, Behr B, Vilardaga JP, Tsien RY, Ellisman MH, and Lohse MJ (2005) A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells. Nat Methods 2:171-176.
24. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, and Schultz G. (1999) Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 397:259-263.
25. Huang Y, Wright CD, Merkwan CL, Baye NL, Liang Q, Simpson PC, and O'Connell TD (2007) An alphal A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes. Circulation 115:763-772.
26. Hur EM and Kim KT (2002) G protein-coupled receptor signalling and cross-talk: achieving rapidity and specificity. Cell Signalling 14:397-405.
27. Kamp TJ and Hell JW (2000) Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 87:1095-1102.
28. Kenakin TP (2004) A Pharmacology Primer: Theory, Application and Methods. Elsevier, Amsterdam.
29. Lohse MJ, Engelhardt S, and Eschenhagen T (2003) What is the role of beta-adrenergic signaling in heart failure?. Circ Res 93:896-906.
30. Lohse MJ, Hein P, Hoffmann C, Nikolaev VO, Vilardaga JP, and Bunemann M (2008a) Kinetics of G-protein-coupled receptor signals in intact cells. Br J Pharmacol 153:S125-S132.
31. Lohse MJ, Nikolaev VO, Hein P, Hoffmann C, Vilardaga JP, and Bunemann M (2008b) Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors. Trends Pharmacol Sci 29:159-165.
32. 2+ entry distinguished using adenylyl cyclase type 8. Mol Pharmacol 70:769-777.
33. Martin SW, Butcher AJ, Berrow NS, Richards MW, Paddon RE, Turner DJ, Dolphin AC, Sihra TS, and Fitzgerald EM (2006) Phosphorylation sites on calcium channel alphal and beta subunits regulate ERK-dependent modulation of neuronal N-type calcium channels. Cell Calcium 39:275-292.
34. Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, and Dei Cas L (2000) Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol Circulation 102:546-551.
35. 2+- selective (ARC) channel activity is modulated by phosphorylation and involves an A-kinase anchoring protein. J Physiol 567:787-798.
36. Milligan G and Smith NJ (2007) Allosteric modulation of heterodimeric G-protein-coupled receptors. Trends Pharmacol Sci 28:615-620.
37. 2+. Pharmacol Rev 40:87-119.
38. O'Connell TD, Swigart PM, Rodrigo MC, Ishizaka S, Joho S, Turnbull L, Tecott LH, Baker AJ, Foster E, Grossman W, et al. (2006) Alphal-adrenergic receptors prevent a maladaptive cardiac response to pressure overload. J Clin Investig 116: 1005-1015.
39. Oldham WM and Hamm HE (2007) How do receptors activate G proteins?. Adv Protein Chem 74:67-93.
40. Perez DM (2005) The Adrenergic Receptors: In the 21st Century. Humana Press, Totowa, NJ.
41. Perez DM (2007) Structure-function of alphal-adrenergic receptors. Biochem Pharmacol 73:1051-1062.
42. Prinster SC, Hague C, and Hall RA (2005) Heterodimerization of g protein-coupled receptors: specificity and functional significance. Pharmacol Rev 57:289-298.
43. Sakata Y, Hoit BD, Liggett SB, Walsh RA, and Dorn GW 2nd (1998) Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice. Circulation 97:1488-1495.
44. Schulz DJ, Temporal S, Barry DM, and Garcia ML (2008) Mechanisms of voltage-gated ion channel regulation: from gene expression to localization. Cell Mol Life Sci 65:2215-2231.
45. Shaw G, Morse S, Ararat M, and Graham FL (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16:869-871.
46. Skomedal T, Borthne K, Aass H, Geiran O, and Osnes JB (1997) Comparison between alpha-1 adrenoceptor-mediated and beta adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle. J Pharmacol Exp Ther 280:721-729.
47. Suzuki F, Morishima S, Tanaka T, and Muramatsu I (2007) Snapin, a new regulator of receptor signaling, augments alphalA-adrenoceptor-operated calcium influx through TRPC6. J Biol Chem 282:29563-29573.
48. 2+ channels. Cell Calcium 40:97-114.
49. Violin JD, DiPilato LM, Yildirim N, Elston TC, Zhang J, and Lefkowitz RJ (2008) beta2-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics. J Biol Chem 283:2949-2961.
50. Violin JD and Lefkowitz RJ (2007) Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 28:416-422.
51. Waugh DJ, Gaivin RJ, Damron DS, Murray PA, and Perez DM (1999) Binding, partial agonism, and potentiation of alpha(l)-adrenergic receptor function by benzodiazepines: A potential site of allosteric. modulation. J Pharmacol Exp Ther 291:1164-1171.
52. 2+. Biochem J 374:281-296.
53. Williams TJ, Blue DR, Daniels DV, Davis B, Elworthy T, Gever JR, Kava MS, Morgans D, Padilla F, Tassa S, et al. (1999) In vitro alphal-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alphalA-adrenoceptor selective antagonists. Br J Pharmacol 127:252-258.
54. Woodall AJ, Richards MA, Turner DJ, and Fitzgerald EM (2008) Growth factors differentially regulate neuronal Cav channels via ERK-dependent signalling. Cell Calcium 43:562-575.
55. Woodcock EA, Du XJ, Reichelt ME, and Graham RM (2008) Cardiac alpha 1-adrenergic drive in pathological remodelling. Cardiovasc Res 77:452-462.
56. Zamponi GW and Snutch TP (2002) Modulating modulation: crosstalk between regulatory pathways of presynaptic calcium channels. Mol Interv 2:476-478.